NASHVILLE, Tennessee ―The retention rate for the antiseizure drug perampanel (Eisai Co, Ltd) is more than 70% for adult patients with epilepsy, new research shows. In […]

Cluster headache (CH) is associated with a significantly increased risk for comorbid conditions, including mental disorders and other neurologic disease, leading to significant disability and absenteeism, […]

NASHVILLE, TENN. — Patients with dementia and active seizures experience faster cognitive and functional decline and have a greater risk of dying younger than people with dementia who […]

A study of more than 4 million births over 20 years in five Scandinavian countries has reported that three antiseizure medications should be used with caution […]

In 1993, managing patients with stroke had long remained an elusive and somewhat intimidating task for the neurological world. Previous efforts to treat the condition had […]

NASHVILLE, TENN. — Medicare and Medicaid spending on antiseizure medications has more than doubled over the past decade, but the number of overall prescriptions hasn’t increased nearly as […]

NASHVILLE, TENN. – Researchers have reported for the first time a process that may explain the progression of absence seizures that seems to provoke dysregulation of the insulating layer […]

People with high stress levels have a significantly higher risk for acute stroke than their counterparts with low stress, but the risk lessens if they feel […]

A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. […]